Guido Matthias Kukuk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Guido Matthias Kukuk has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Frank Träber
Department of Radiology, University of Bonn, Bonn, Germany
7 shared publications Hans H. Schild
University of Bonn
7 shared publicationsWinfried A. Willinek
University of Bonn
7 shared publications- Hans Heinz Schild
Department of Radiology, University of Bonn, Sigmund-Freud-Str.25, 53127 Bonn, Germany
5 shared publications Jürgen Gieseke
University of Bonn
5 shared publications- Alois Martin Sprinkart
Department of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany
4 shared publications
Latest Publications
- 9 January 2018
- Published by Springer Nature in Der Radiologe
- Vol. 58 (1) , 25-35
Benigne mesenchymale Tumoren des Abdomens
Benigne mesenchymale Tumoren des Abdomens sind, abgesehen von Hämangiomen, seltene Neoplasien, die mit vital bedrohlichen Komplikationen einhergehen können. Daher sind für den Radiologen die Kenntnis der wichtigsten Entitäten und das Wissen um deren Charakteristika in der Bildgebung fundamental.
- 9 January 2018
- Published by Springer Nature in Der Radiologe
- Vol. 58 (1) , 25-35
Benigne mesenchymale Tumoren des Abdomens
Benigne mesenchymale Tumoren des Abdomens sind, abgesehen von Hämangiomen, seltene Neoplasien, die mit vital bedrohlichen Komplikationen einhergehen können. Daher sind für den Radiologen die Kenntnis der wichtigsten Entitäten und das Wissen um deren Charakteristika in der Bildgebung fundamental.
- 1 September 2017
- Published by Georg Thieme Verlag KG in Radiologie up2date
- Vol. 17 (03) , 231-248
Diagnostik der Fettleber
Zusammenfassung: Die verschiedenen Ausprägungen der Fettleber gehören in den Industrienationen zu den häufigsten Ursachen für chronische Lebererkrankungen. Da eine Leberverfettung prinzipiell reversibel ist, kann eine frühe Diagnose die Voraussetzung dafür schaffen, dass therapeutische Maßnahmen rechtzeitig eingeleitet werden. Die vorliegende Arbeit beschreibt die wesentlichen diagnostischen Methoden und die jeweiligen Vor- und Nachteile der einzelnen Verfahren.
- 1 September 2017
- Published by Georg Thieme Verlag KG in Radiologie up2date
- Vol. 17 (03) , 231-248
Diagnostik der Fettleber
Zusammenfassung: Die verschiedenen Ausprägungen der Fettleber gehören in den Industrienationen zu den häufigsten Ursachen für chronische Lebererkrankungen. Da eine Leberverfettung prinzipiell reversibel ist, kann eine frühe Diagnose die Voraussetzung dafür schaffen, dass therapeutische Maßnahmen rechtzeitig eingeleitet werden. Die vorliegende Arbeit beschreibt die wesentlichen diagnostischen Methoden und die jeweiligen Vor- und Nachteile der einzelnen Verfahren.
- 1 March 2017
- Published by Georg Thieme Verlag KG in Radiologie up2date
- Vol. 17 (01) , 83-103
Diffusionsbildgebung: Technik und klinische Anwendung
Während die Diffusionsbildgebung früher überwiegend zur Diagnostik der zerebralen Ischämie eingesetzt wurde, hat sie mittlerweile ein breites Indikationsspektrum in der MRT-Diagnostik. Insbesondere die onkologische Bildgebung, zunehmend aber auch entzündliche Erkrankungen gehören mittlerweile zu den Haupteinsatzgebieten. Die vorliegende Arbeit befasst sich mit den Grundlagen der Diffusionsbildgebung und ihren wichtigsten Indikationen.
- 1 March 2017
- Published by Georg Thieme Verlag KG in Radiologie up2date
- Vol. 17 (01) , 83-103
Diffusionsbildgebung: Technik und klinische Anwendung
Während die Diffusionsbildgebung früher überwiegend zur Diagnostik der zerebralen Ischämie eingesetzt wurde, hat sie mittlerweile ein breites Indikationsspektrum in der MRT-Diagnostik. Insbesondere die onkologische Bildgebung, zunehmend aber auch entzündliche Erkrankungen gehören mittlerweile zu den Haupteinsatzgebieten. Die vorliegende Arbeit befasst sich mit den Grundlagen der Diffusionsbildgebung und ihren wichtigsten Indikationen.
- 1 December 2016
- Published by Elsevier in European Journal of Radiology
- Vol. 85 (12) , 2169-2173
In-bore transrectal MRI-guided prostate biopsies: Are there risk factors for complications?
- 1 December 2016
- Published by Elsevier in European Journal of Radiology
- Vol. 85 (12) , 2169-2173
In-bore transrectal MRI-guided prostate biopsies: Are there risk factors for complications?
- 1 July 2016
- Published by Elsevier in European Journal of Radiology
- Vol. 85 (7) , 1304-1311
Differentiation of prostatitis and prostate cancer using the Prostate Imaging—Reporting and Data System (PI-RADS)
- 1 July 2016
- Published by Elsevier in European Journal of Radiology
- Vol. 85 (7) , 1304-1311
Differentiation of prostatitis and prostate cancer using the Prostate Imaging—Reporting and Data System (PI-RADS)
- 28 April 2016
- Published by Walter de Gruyter GmbH in TM - Technisches Messen
- Vol. 83 (5) , 257-265
Messung von Fettgehalt und Fettvolumen mittels 1H-MR-spektroskopischer Relaxometrie und quantitativer MR-Bildgebung
Zusammenfassung Die Bestimmung des relativen Fettgehaltes der Leber und die Volumetrie von Fettgewebe gewinnt in der radiologischen Diagnostik und in wissenschaftlichen Anwendungen zunehmend an Bedeutung. Die vorliegende Arbeit vergleicht Verfahren der MR-spektroskopischen Relaxometrie und der Magnetresonanztomographie zur Bestimmung des Fettgehaltes von Gewebe und stellt eine Methode zur Volumetrie von kardialem Fettgewebe vor.
- 28 April 2016
- Published by Walter de Gruyter GmbH in TM - Technisches Messen
- Vol. 83 (5) , 257-265
Messung von Fettgehalt und Fettvolumen mittels 1H-MR-spektroskopischer Relaxometrie und quantitativer MR-Bildgebung
Zusammenfassung Die Bestimmung des relativen Fettgehaltes der Leber und die Volumetrie von Fettgewebe gewinnt in der radiologischen Diagnostik und in wissenschaftlichen Anwendungen zunehmend an Bedeutung. Die vorliegende Arbeit vergleicht Verfahren der MR-spektroskopischen Relaxometrie und der Magnetresonanztomographie zur Bestimmung des Fettgehaltes von Gewebe und stellt eine Methode zur Volumetrie von kardialem Fettgewebe vor.
- 1 April 2016
- Published by Elsevier in European Journal of Radiology
- Vol. 85 (4) , 707-713
MRI of the lung using the PROPELLER technique: Artifact reduction, better image quality and improved nodule detection
- 1 April 2016
- Published by Elsevier in European Journal of Radiology
- Vol. 85 (4) , 707-713
MRI of the lung using the PROPELLER technique: Artifact reduction, better image quality and improved nodule detection
- 1 December 2015
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 33 (10) , 1258-1266
Abdominal vasculature in dynamic contrast-enhanced liver MRI at 3.0 T: an intraindividual comparative study using gadoxetate disodium and gadofosveset trisodium
- 1 December 2015
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 33 (10) , 1258-1266
Abdominal vasculature in dynamic contrast-enhanced liver MRI at 3.0 T: an intraindividual comparative study using gadoxetate disodium and gadofosveset trisodium
- 23 April 2015
- Published by Springer Nature in European Radiology
- Vol. 25 (10) , 2869-2879
Comparison between modified Dixon MRI techniques, MR spectroscopic relaxometry, and different histologic quantification methods in the assessment of hepatic steatosis
To compare systematically quantitative MRI, MR spectroscopy (MRS), and different histological methods for liver fat quantification in order to identify possible incongruities. Fifty-nine consecutive patients with liver disorders were examined on a 3 T MRI system. Quantitative MRI was performed using a dual- and a six-echo variant of the modified Dixon (mDixon) sequence, calculating proton density fat fraction (PDFF) maps, in addition to single-voxel MRS. Histological fat quantification included estimation of the percentage of hepatocytes containing fat vesicles as well as semi-automatic quantification (qHisto) using tissue quantification software. In 33 of 59 patients, the hepatic fat fraction was >5 % as determined by MRS (maximum 45 %, mean 17 %). Dual-echo mDixon yielded systematically lower PDFF values than six-echo mDixon (mean difference 1.0 %; P < 0.001). Six-echo mDixon correlated excellently with MRS, qHisto, and the estimated percentage of hepatocytes containing fat vesicles (R = 0.984, 0.967, 0.941, respectively, all P < 0.001). Mean values obtained by the estimated percentage of hepatocytes containing fat were higher by a factor of 2.5 in comparison to qHisto. Six-echo mDixon and MRS showed the best agreement with values obtained by qHisto. Six-echo mDixon, MRS, and qHisto provide the most robust and congruent results and are therefore most appropriate for reliable quantification of liver fat. • Six-echo mDixon correlates excellently with MRS, qHisto, and the estimated percentage of fat-containing hepatocytes. • Six-echo mDixon, MRS, and qHisto provide the most robust and congruent results. • Dual-echo mDixon yields systematically lower PDFF values than six-echo mDixon. • The percentage of fat-containing hepatocytes is 2.5-fold higher than fat fraction determined by qHisto. • Performance characteristics and systematic differences of the various methods should be considered.
- 23 April 2015
- Published by Springer Nature in European Radiology
- Vol. 25 (10) , 2869-2879
Comparison between modified Dixon MRI techniques, MR spectroscopic relaxometry, and different histologic quantification methods in the assessment of hepatic steatosis
To compare systematically quantitative MRI, MR spectroscopy (MRS), and different histological methods for liver fat quantification in order to identify possible incongruities. Fifty-nine consecutive patients with liver disorders were examined on a 3 T MRI system. Quantitative MRI was performed using a dual- and a six-echo variant of the modified Dixon (mDixon) sequence, calculating proton density fat fraction (PDFF) maps, in addition to single-voxel MRS. Histological fat quantification included estimation of the percentage of hepatocytes containing fat vesicles as well as semi-automatic quantification (qHisto) using tissue quantification software. In 33 of 59 patients, the hepatic fat fraction was >5 % as determined by MRS (maximum 45 %, mean 17 %). Dual-echo mDixon yielded systematically lower PDFF values than six-echo mDixon (mean difference 1.0 %; P < 0.001). Six-echo mDixon correlated excellently with MRS, qHisto, and the estimated percentage of hepatocytes containing fat vesicles (R = 0.984, 0.967, 0.941, respectively, all P < 0.001). Mean values obtained by the estimated percentage of hepatocytes containing fat were higher by a factor of 2.5 in comparison to qHisto. Six-echo mDixon and MRS showed the best agreement with values obtained by qHisto. Six-echo mDixon, MRS, and qHisto provide the most robust and congruent results and are therefore most appropriate for reliable quantification of liver fat. • Six-echo mDixon correlates excellently with MRS, qHisto, and the estimated percentage of fat-containing hepatocytes. • Six-echo mDixon, MRS, and qHisto provide the most robust and congruent results. • Dual-echo mDixon yields systematically lower PDFF values than six-echo mDixon. • The percentage of fat-containing hepatocytes is 2.5-fold higher than fat fraction determined by qHisto. • Performance characteristics and systematic differences of the various methods should be considered.
- 23 April 2015
- Published by Springer Nature in European Radiology
- Vol. 25 (11) , 3207-3213
Respiratory motion artefacts in dynamic liver MRI: a comparison using gadoxetate disodium and gadobutrol
Our aim was to retrospectively evaluate the occurrence of respiratory motion artefacts in patients undergoing dynamic liver magnetic resonance (MR) either with gadoxetate disodium or gadobutrol. Two hundred and thirty liver MR studies (115 with gadobutrol, 115 with gadoxetate disodium) were analysed. Respiratory motion artefacts on dynamic 3D T1-weighted MR images (pre-contrast, arterial, venous, and late-dynamic phase) were assessed using a five-point rating scale. Severe motion was defined as a score ≥ 4. Mean motion scores were compared with the Mann-Whitney-U-test. The chi-squared-test was used for dichotomous comparisons. Mean motion scores for gadoxetate disodium and gadobutrol showed no relevant differences for each phase of the dynamic contrast series (pre-contrast: 1.85 ± 0.70 vs. 1.88 ± 0.57, arterial: 1.85 ± 0.81 vs. 1.87 ± 0.74, venous: 1.82 ± 0.67 vs. 1.74 ± 0.64, late-dynamic: 1.75 ± 0.62 vs. 1.79 ± 0.63; p = 0.469, 0.557, 0.382 and 0.843, respectively). Severe motion artefacts had a similar incidence using gadoxetate disodium and gadobutrol (11/460 [2.4 %] vs. 7/460 [1.5 %]; p = 0.341). Gadoxetate disodium is associated with equivalent motion scores compared to gadobutrol in dynamic liver MRI. In addition, both contrast agents demonstrated a comparable and acceptable rate of severe respiratory motion artefacts. • Gadobutrol and gadoxetate disodium showed comparable motion scores in dynamic phase imaging. • The incidence of severe motion artefacts was pronounced in arterial phase imaging. • Adverse respiratory side effects were not recorded in 115 examinations with gadoxetate disodium.
- 23 April 2015
- Published by Springer Nature in European Radiology
- Vol. 25 (11) , 3207-3213
Respiratory motion artefacts in dynamic liver MRI: a comparison using gadoxetate disodium and gadobutrol
Our aim was to retrospectively evaluate the occurrence of respiratory motion artefacts in patients undergoing dynamic liver magnetic resonance (MR) either with gadoxetate disodium or gadobutrol. Two hundred and thirty liver MR studies (115 with gadobutrol, 115 with gadoxetate disodium) were analysed. Respiratory motion artefacts on dynamic 3D T1-weighted MR images (pre-contrast, arterial, venous, and late-dynamic phase) were assessed using a five-point rating scale. Severe motion was defined as a score ≥ 4. Mean motion scores were compared with the Mann-Whitney-U-test. The chi-squared-test was used for dichotomous comparisons. Mean motion scores for gadoxetate disodium and gadobutrol showed no relevant differences for each phase of the dynamic contrast series (pre-contrast: 1.85 ± 0.70 vs. 1.88 ± 0.57, arterial: 1.85 ± 0.81 vs. 1.87 ± 0.74, venous: 1.82 ± 0.67 vs. 1.74 ± 0.64, late-dynamic: 1.75 ± 0.62 vs. 1.79 ± 0.63; p = 0.469, 0.557, 0.382 and 0.843, respectively). Severe motion artefacts had a similar incidence using gadoxetate disodium and gadobutrol (11/460 [2.4 %] vs. 7/460 [1.5 %]; p = 0.341). Gadoxetate disodium is associated with equivalent motion scores compared to gadobutrol in dynamic liver MRI. In addition, both contrast agents demonstrated a comparable and acceptable rate of severe respiratory motion artefacts. • Gadobutrol and gadoxetate disodium showed comparable motion scores in dynamic phase imaging. • The incidence of severe motion artefacts was pronounced in arterial phase imaging. • Adverse respiratory side effects were not recorded in 115 examinations with gadoxetate disodium.